Skip to main content
. 2020 Oct 19;3(10):e2020425. doi: 10.1001/jamanetworkopen.2020.20425

Figure 1. Flowchart of Participants in Bevacizumab-Avastin Adjuvant (AVANT) and Long-term Survival Bevacizumab-Avastin Adjuvant (S-AVANT) Studies.

Figure 1.

FOLFOX4 indicates 5-fluorouracil, leucovorin, and oxaliplatin; and XELOX, capecitabine and oxaliplatin.